#129641
Re: Farmas USA
CBIO
Catalyst Biosciences Receives FDA Fast Track Designation for Subcutaneous MarzAA for the Treatment of Episodic Bleeding in Factor VII Deficiency
https://ir.catalystbiosciences.com/news-releases/news-release-details/catalyst-biosciences-receives-fda-fast-track-designation-0
Catalyst Biosciences Receives FDA Fast Track Designation for Subcutaneous MarzAA for the Treatment of Episodic Bleeding in Factor VII Deficiency
https://ir.catalystbiosciences.com/news-releases/news-release-details/catalyst-biosciences-receives-fda-fast-track-designation-0
«Después de nada, o después de todo/ supe que todo no era más que nada.»